Home / Research Tools
Research Tools
| Corporate Profile: Diagnos Inc Publisher: Kaiser Research Online Author: Copyright 2013 John A Kaiser
|
|
Diagnos Inc (ADK-V) |
Trade Date | Volume | High | Low | Close | Chg | Status |
March 27, 2024 | 98,800 | $0.25 | $0.23 | $0.24 | ($0.02) | Trading |
Issued 21,293,126 |
Price $0.235 |
Working Capital ($689,990) |
Key People: Andre Larente (Pres), Marc-Andre Massue (CFO), Michel Fontaine (VP CD), |
Diluted 27,061,394 |
Insiders 15.7% |
As of 12/31/2018 |
Company supplied Corporate Overview - not available |
The free corporate profile serves as a fast gateway for KRO members via the map cards to resources such as the KRO Profile which includes financial, insider and project details as well as news releases and KRO comments for which headline links are provided below. Links to the company's web site and project web pages are available within this free corporate profile if the company has a multi-user corporate membership (they are always available in full member only KRO Profile). A corporate membership provides the company with complete multiple user access to KRO resources and entitles the company to provide a corporate overview for the subject company's unrestricted corporate profile. |
Mar 22, 2024 | Closing of Second and Final Tranche of Private Placement |
Mar 4, 2024 | Grant of Stock Options |
Feb 29, 2024 | Welcomes Mr. Michael Braeuel to its Board of Directors |
Feb 27, 2024 | Closing of First Tranche of Private Placement |
Feb 23, 2024 | Variation in One Insider Ownership of Common Shares |
Feb 21, 2024 | Recognized as a Top TSX Venture Exchange Company |
Jan 16, 2024 | Appoints New Chief Operating Officer |
Dec 11, 2023 | BULLETIN V2023 0221; Resume Trading |
Dec 11, 2023 | Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica, a Global Leader in Vision Care |
Dec 7, 2023 | Private Placement Non Brokered |
Dec 4, 2023 | Closing of Private Placement |
Oct 5, 2023 | AI Retina Analysis is being deployed across Canadas Largest Specialist Care Provider in Diabetes & Endocrinology |
May 26, 2023 | Private Placement non brokered, Convertible Debentures |
May 18, 2023 | Closing of Private Placement and Exercise of Stock Warrants |
May 17, 2023 | DIAGNOS and IRIS, The Visual Group Strengthen Partnership with the Launch of IRIS ai Powered by DIAGNOS |
Feb 28, 2023 | DIAGNOS and ETS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts |
Feb 14, 2023 | DIAGNOS and ETS to Present Ground breaking Research on Mass Screening for Macular Edema at ARVO 2023 |
Feb 10, 2023 | Grant of Stock Options |
Jan 31, 2023 | Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals |
Jan 25, 2023 | Private Placement non brokered, Convertible Debentures |
Jan 13, 2023 | Closing of Private Placement |
Dec 21, 2022 | Private Placement non brokered, Convertible Debentures |
Dec 15, 2022 | Provides Additional Information to the Closing of Private Placement |
Dec 12, 2022 | Closing of Private Placement |
Nov 25, 2022 | Closing of Private Placement |
Oct 27, 2022 | Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology |
Sep 1, 2022 | Closing of Private Placement |
Aug 18, 2022 | Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems |
Jul 27, 2022 | Continues Expansion in Canada with Kick off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics |
Jun 23, 2022 | Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance |
Jun 7, 2022 | Deployment of its Age Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group |
May 26, 2022 | DIAGNOS and the CHUM are Launching the Testing Phase of Autonomous Artificial Intelligence Solutions Dedicated to Diabetic Retinopathy Screening |
May 10, 2022 | a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico |
Apr 26, 2022 | The Extension of its Contract with Novo Nordisk for the Follow up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio |
Mar 30, 2022 | Private Placement non brokered, Convertible Debenture |
Mar 28, 2022 | Closing of Private Placement and New Marketing Director |
Mar 15, 2022 | CAN Health Network and Quebec Based DIAGNOS Announce Life Changing Diabetic Retinopathy Screening Program Partnership |
Mar 1, 2022 | Closing of Private Placement |
Feb 10, 2022 | Successfully Completes ISO / MDSAP Audit |
Jan 26, 2022 | Provides Corporate Update for 2021 and Outlook for 2022 |
Nov 23, 2021 | Will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA STROKE. |
Oct 28, 2021 | Delivers World Class Results in the MICCAI2021 Contest: GAMMA |
Sep 16, 2021 | A Multi Year Contract with Juarez Health & Medical Tourism Cluster |
Sep 14, 2021 | 3 Year Contract with Cielo Vista Eye Clinic in Mexico |
Sep 10, 2021 | Voting Results of Annual Meeting of Shareholders |
Sep 2, 2021 | Three Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer's Disease Test |
Aug 17, 2021 | Date of Annual General and Special Meeting of Shareholders |
Aug 16, 2021 | Signs Memorandum of Understanding with Essilor International. |
Aug 5, 2021 | A.I. retinal screening technology expands into international markets |
Jul 28, 2021 | A Pilot with Opticalia in Spain |
Jul 22, 2021 | The Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia |
Jul 20, 2021 | Initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA STROKE |
Jun 15, 2021 | A Pilot with Hospital Oftalmologico Buena Vista Sinaloa |
Jun 9, 2021 | IRIS teams up with DIAGNOS in a multi year agreement to implement Artificial Intelligence technology with support from the INVEST AI Program |
Apr 6, 2021 | Enters into an Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People |
Mar 9, 2021 | Following a successful Proof of Concept (POC) pilot study, is finalising its new application CARA STROKE to address Stroke prevention and management, a market estimated at $36 Billion |
Mar 4, 2021 | Third Largest Optical Retailer in Costa Rica Piloting CARA and its Telemedicine technology |
Mar 3, 2021 | Stock Options Grants |
Feb 26, 2021 | Exercise Of Stock Warrants And Provides A Cash Update |
Feb 24, 2021 | Its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and |
Feb 2, 2021 | Further Deployment of its AI based CARA Technology in Saudi Arabia |
Jan 28, 2021 | The Re Opening of its Medical Testing in Panama |
Jan 21, 2021 | Successfully Completes ISO 13485 / MDSAP Audit |
Jan 19, 2021 | A 3 year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence |
Jan 14, 2021 | Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients |
Jan 5, 2021 | Provides Market Activity Update |
Nov 12, 2020 | The Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al Mutairi for his Assignment as Secretary General of the Council of Private |
Nov 5, 2020 | 9071 8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc. |
Oct 8, 2020 | Warrant Term Extension |
Oct 7, 2020 | Stock Warrants Term Extension |
Oct 6, 2020 | Mexico's Largest Optical Retailer to Use DIAGNOS' AI Technology to Detect Early Stage Blindness |
Sep 28, 2020 | Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors |
Sep 15, 2020 | A Multi Year Contract with Chaparral Medical Group in California |
Sep 8, 2020 | Receives $2,000,000 Assistance from Quebec |
Aug 26, 2020 | Annual General Meeting of Shareholders Date and Attendance Special Measures |
Jul 14, 2020 | Signing of Service Agreement with the Colombian Telemedicine Centre |
Jul 7, 2020 | Client in California, the Chaparral Medical Group of Clinics, is Reopening the Screening Services for Diabetic Retinopathy after the COVID 19 Shutdown |
Jun 3, 2020 | Signing of Strategic Partnership Agreement with Labtician Ophthalmics, Leading Global Ophthalmology Product and Equipment Supplier |
Apr 27, 2020 | Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program |
Mar 27, 2020 | Stock Options Grant |
Mar 25, 2020 | Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the 'US White House Call to Action' to Analyse and Transform COVID 19 Data into Clinical Knowledge |
Mar 11, 2020 | Private Placement Non Brokered |
Mar 9, 2020 | Closing of Oversubscribed $2.1 Million Private Placement |
Feb 19, 2020 | Shares for Debt |
Feb 14, 2020 | Shares for Debt Transaction |
Jan 14, 2020 | Successfully Completes ISO 13485 / MDSAP Surveillance Audit |
Jan 7, 2020 | AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months |
Dec 12, 2019 | A New Strategic Partnership Agreement in Costa Rica |
Dec 10, 2019 | Collaborative Agreement in the North American Borderplex Region |
Nov 28, 2019 | Welcomes Mr. Francis Bellido to its Board of Directors |
Nov 26, 2019 | Short Term Financing |
Oct 29, 2019 | Local Partner Selected Following a Competitive Bid from the Mexican Government |
Sep 25, 2019 | Appoints New Chairman of the Board of Directors |
Sep 20, 2019 | Voting Results of Annual Meeting of Shareholders |
Sep 16, 2019 | Closing of a Private Placement |
Sep 13, 2019 | Private Placement |
Sep 10, 2019 | Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia |
Sep 3, 2019 | An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM |
Jun 20, 2019 | An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM |
Jun 18, 2019 | Welcomes Mr. Francois Cote to its Board of Directors |
Jun 17, 2019 | Short Term Financing |
Jun 10, 2019 | Corporate Reorganization Update |
Jun 6, 2019 | HIPAA Compliance for the US Market |
Jun 4, 2019 | The Appointment Of Mr. Riadh Kobbi As Vice President Business Intelligence |
May 30, 2019 | Opening Of Two New Screening Clinics In Hafar Al Batin, To Screen 10,000 Patients In The Next Six Months With Its Partner Kanhoor Medical Co. |
May 28, 2019 | Adds a Second Screening Site at the CHUM in the Ophthalmology Department |
May 15, 2019 | Completes Redemption of Convertible Debt |
May 7, 2019 | Saudi FDA Filing for its CARA AI Platform |
May 1, 2019 | Joins Forces with a Cannabis Based Medicinal Products Distributor |
Apr 30, 2019 | Redeems Convertible Debt |
Apr 23, 2019 | Successfully Completes ISO 13485:2016 MDSAP Audit |
Apr 16, 2019 | Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia. |
Apr 10, 2019 | Approval of Corporate Reorganization |
Apr 2, 2019 | New Contract with Government in Bangladesh Through its Partner Eyes for All |
Mar 27, 2019 | An Update to the News Release Issued Earlier Today |
Mar 27, 2019 | Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO application |
Mar 13, 2019 | New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the World |
Jan 29, 2019 | Welcomes Dr. Jean Francois Yale to the Board of Directors |
Jan 22, 2019 | An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM |
Dec 4, 2018 | Collaboration with TS on Automated detection and grading of Diabetic Retinopathy using Deep Convolutional Neural Networks, (CNN) a new generation of Deep Learning Technique |
Nov 21, 2018 | Enters into a Shares for Debt Transaction |
Nov 13, 2018 | Addition of a Strategic Partner in the Country of Mexico |
Nov 9, 2018 | Closing of Private Placement |
Nov 6, 2018 | Private Placement of Common Stocks and Stock Warrants |
Nov 1, 2018 | Closing of Private Placement of Common Stocks and Stock Warrants |
Oct 24, 2018 | Private Placement Of Common Stocks And Stock Warrants & Shares For Debt |
Sep 18, 2018 | To Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United States |
Sep 11, 2018 | Closing Of Private Placement Of Common Stocks And Stock Warrants |
Sep 5, 2018 | Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease |
Aug 24, 2018 | Private Placement of Common Stocks and Stock Warrants |
Jul 31, 2018 | Update on Business Operations |
Jul 10, 2018 | Installs its First Retina Screening Clinic based on Artificial Intelligence in Panama |
Jul 5, 2018 | Closes Second and Final Tranche of Private Placement |
Jul 4, 2018 | Broadens Collaboration With Government Of Mexico |
Jun 29, 2018 | Provides Financing Updates |
Jun 18, 2018 | Private Placement Non Brokered |
Jun 14, 2018 | Hires Investor Relation Firm Momentum Public Relations and Provides Financing Update |
Jun 12, 2018 | Availability Of New CARA High Blood Pressure Risk Assessment Based On FLAIRE Artificial Intelligence Platform |
Jun 7, 2018 | Presents a Technological Showcase at the CHUM with the Opening of an Automated Diabetic Retinopathy Screening Clinic Assisted by AI (Artificial Intelligence) with Financial Support of the Quebec |
May 28, 2018 | Private Placement And Stock Options Grant |
Apr 6, 2018 | Diagnos Inc. Sells 10,500,000 Common Shares Of Albert Mining Inc. |
Apr 4, 2018 | Welcomes Dr. Reid Maclellan to the Board of Directors |
Mar 14, 2018 | The Opening of a Screening Clinic at Chaparral's Health Management Wellness Center for Medicare Beneficiaries |
Mar 7, 2018 | Following a successful year, DIAGNOS Announces a One Year Agreement in United Arabs Emirates with a Major Pharmaceutical Company |
Feb 27, 2018 | After Successful Screening Of 2,500 Patients As Part Of A Pilot Project With Kanhoor Medical Co, DIAGNOS Will Now Screen 35,000 patients In The Kingdom Of Saudi Arabia |
Feb 14, 2018 | Provides A Market Update On Recent Trading |
Feb 8, 2018 | Sells Shares in Diagnos Inc. |
Jan 25, 2018 | Arrowhead Business And Investment Decisions Initiates Analyst Coverage Of DIAGNOS |
Jan 17, 2018 | Next Release of its CARA Artificial Intelligence Platform Will Rely on Blockchain Technology for Security Control of Medical Records |
Jan 10, 2018 | The Management of the Flagship Nuevo Yo Program by Novo Nordisk |
Dec 19, 2017 | Successfully Passed ISO Annual Surveillance Audit |
Dec 6, 2017 | Receives Support From Export Development Canada (EDC) For The Issuance Of A Performance Bond For The Issste Contract |
Nov 29, 2017 | Hires Investor Relation Firm Arrowhead Business And Investment Decisions, Llc And Grants Stock Options |
Nov 22, 2017 | A Second Contract For Its Cardio Platform With A Multinational Pharmaceutical Company And The Resignation Of A Director |
Nov 9, 2017 | New Project With Cardiology Department Of The Centre National De Medecine Du Sport C.n.m.s Hospital Located In Alger, Algeria, Before Product Launch |
Oct 24, 2017 | A One year Agreement In North Africa With A Major Pharmaceutical Company After Successful Pilot |
Oct 23, 2017 | Private Placement Non Brokered, Convertible Debenture |
Oct 23, 2017 | Closes Second Tranche Of Private Placement |
Oct 17, 2017 | A New Partner In Cambodia, Garuda Health Services |
Oct 16, 2017 | Closing Of A Private Placement |
Sep 26, 2017 | Dtc Eligibility Of Its Common Shares In The Us |
Sep 19, 2017 | Provides Timelines On Cardiovascular Disease (cvd) Prevention Test Development And Commercialization Plans |
Aug 28, 2017 | Restatement Of March 31, 2017 Financial Statements Which Resulted In A Decrease In Expenses Of $2,491,096 |
Aug 22, 2017 | 2 Screening Clinics With Al Kahhal Medical Complex In The Kingdom Of Saudi Arabia |
Aug 14, 2017 | Results From The Annual Meeting Of Shareholders, Appointments Of New Chairman And New Chief Medical Officer And Stock Options Grant |
Jul 17, 2017 | Resume Trading |
Jul 17, 2017 | Signs New Contract Valued At $ 4.16 Million USD (5.26 Million CAD) With The Government Of Mexico At ISSSTE To Screen And Monitor 320,000 Diabetics In 2017 |
Jul 5, 2017 | Successful Pilot At Chaparral Medical Group In California And A 3 Year Contract With The Opening Of A Second Eye Screening Clinic |
Jun 27, 2017 | Receives Approval For Trading On The OTCQB Venture Market |
Jun 12, 2017 | Amendment To Its Stock Option Plan |
May 31, 2017 | New Mission In Healthcare After Its Divestiture From The Mining Industry |
May 17, 2017 | Diagnos Acquires Interest In Majescor Resources Inc. |
May 4, 2017 | Shares for Debt |
May 4, 2017 | Private Placement Non Brokered, Convertible Debenture |
Apr 28, 2017 | Private Placement Closing Update |
Apr 27, 2017 | Closing Of Private Placement |
Apr 24, 2017 | New Partnership In Bangladesh With Eyes For All |
Apr 13, 2017 | Private Placement |
Mar 15, 2017 | Diagnos, In A Strategic Move, Is Divesting Its Mining Division To Focus On Detection Of Critical Health Issues Through The Use Of Its Artificial Intelligence Platform |
Feb 22, 2017 | Contract In The Kingdom Of Saudi Arabia With Alkanhoor Medical Co. |
Feb 14, 2017 | Contract Extension With The Mexican Government And An Update For A Two year Potential National Coverage Program |
Jan 26, 2017 | Nippon Dragon Resources Will Use Diagnos' Artificial Intelligence Tools To Optimize Exploration Of Its Rocmec1 And Denain Properties |
Jan 24, 2017 | Successfully Completes A 2,000 Patient Pilot Project For The Mexican Social Security Institute |
Jan 11, 2017 | Appoints New Director Mr. Georges Hebert |
Jan 10, 2017 | Update On An Artificial Intelligence Digital Healthcare Solution Contract With Issste, An Organization Of The Mexican Government |
Dec 21, 2016 | Monarques Gold Corp. Will Use Diagnos Artificial Intelligence Tools To Optimize Exploration Of Croinor Gold |
Dec 13, 2016 | Successfully Passed Iso Certification Surveillance Audit |
Dec 6, 2016 | Bayer Canada And Diagnos Join Efforts Against Diabetes |
Dec 2, 2016 | Grants Stock Options |
Nov 29, 2016 | Appoints New Director Dr. Netan Choudhry |
Nov 21, 2016 | Diagnos Sells A Purchase Option To Majescor Resources For 131 Mining Claims Which Comprise 37 Kimberlite Targets Near The Renard Diamond Mine And Adamantin Project In Quebec |
Nov 14, 2016 | A Pilot Project With The National Social Security System Of Mexico |
Oct 25, 2016 | A New Pilot Contract In The South East Asia Region |
Oct 18, 2016 | Two New Pilot Projects Contracts In North Africa |
Oct 13, 2016 | Rights Offering Shares |
Sep 26, 2016 | Appoints New Vice president And Grants Stock Options |
Sep 14, 2016 | Closes Rights Offering For Gross Proceeds Of $1m |
Sep 14, 2016 | Staked 131 New Property Claims Covering 37 Kimberlite Targets On The Same Areas As The New Diamond Renard Mine And Adamantin Project In Quebec |
Sep 7, 2016 | Operational Update For A Project With A Mexican Government Organization |
Sep 6, 2016 | Rights Expiry Delist |
Aug 10, 2016 | Private Placement Non Brokered, Convertible Debenture |
Jul 27, 2016 | Diagnos Announces: Majescor And Eastmain Resources Have Mobilized Teams To Start Its Prospecting Program On Diagnos Gold Targets In The Former Eastmain Mine Area (James Bay) |
Jul 22, 2016 | Private Placement |
Jul 21, 2016 | Rights Offering Shares |
Jul 21, 2016 | Rights Offering |
Jul 5, 2016 | Operational Update Of A Contract In India Valued At Up To $1.3m |
Jun 13, 2016 | Shares for Bonuses |
Jun 8, 2016 | Major Strategic Alliance In Latin America For A Contract Of $1.38 M Usd |
Jun 7, 2016 | Short Term Financing |
May 20, 2016 | Changes To Its Board Of Directors |
May 19, 2016 | Private Placement Non Brokered, Convertible Debenture |
May 18, 2016 | Update Following Closing Of Private Placement |
May 4, 2016 | Shares for Bonuses |
May 3, 2016 | Closing Of Private Placement |
Apr 27, 2016 | Everton Acquires 136 Claims For Gold Targets Using Diagnos Cards System In Detour Lake Area, Quebec |
Apr 25, 2016 | Short Term Financing |
Apr 7, 2016 | Private Placement |
Apr 4, 2016 | Shares for Bonuses |
Mar 22, 2016 | Short Term Financing |
Feb 26, 2016 | Financing Update |
Jan 11, 2016 | Non brokered Private Placement |
Jan 7, 2016 | Eloro Resources Issues Shares For Acquisition Of Geological Information Delivered Pursuant To A Services Agreement With Diagnos |
Nov 18, 2015 | Bayer And Diagnos Join Efforts Against Diabetes |
Sep 25, 2015 | Results From Annual Meeting Of Shareholders |
Sep 23, 2015 | Provides General Business Update |
Sep 1, 2015 | Closing Of Second Tranche Of Private Placement |
Sep 1, 2015 | Private Placement Brokered, Convertible Debenture |
Aug 28, 2015 | Amendment To Its Stock Option Plan |
Jul 30, 2015 | Closes Private Placement Of Convertible Debentures |
Jul 14, 2015 | Correction From Source: Diagnos Announces Impressive Results For The Automatic Detection Of Glaucoma Using Cara Algorithms |
Jun 30, 2015 | Appoints New Executive Chairman & Announces Concurrent Private Placement |
Jun 22, 2015 | Contract With Global Pharmaceutical Company In Mexico |
Jun 16, 2015 | Industry Leading Performance Of Its Automated Dark Lesion Detection For Diabetic Retinopathy Screening |
May 27, 2015 | A Strategic Alliance With The Largest Private Hospital Group In Latin America To Unburden Diabetes In The Public Health System |
May 19, 2015 | Darc Chooses Cara For A Clinical Trial In Conjunction With A Top Five Pharmaceutical Company In The United States |
May 4, 2015 | Licensing Deal With Inb Al Haythem Center In Algeria |
Apr 14, 2015 | Licensing Deal With Clinique Hamouche In Algeria |
Apr 10, 2015 | Retina Screening Project With Clinique Chifa Hydra In Algeria |
Apr 1, 2015 | Review Of Cadillac Break Property Geophysics Yields Strong Targets |
Mar 26, 2015 | Two Year Renewal Of Successful Program In The Uae |
Mar 18, 2015 | First Screening Project In Poland With Globally Leading Pharmaceutical Company |
Mar 10, 2015 | Contract With A Leading Ophthalmology Pharmaceutical Company In The USA |
Mar 5, 2015 | Strategic Restructuring To Focus On Healthcare |
Feb 17, 2015 | Pilot With A Major Public Health Institution In Mexico For Retinopathy Screening |
Feb 12, 2015 | Opens Polish Subsidiary Diagnos Poland Sp. Z O.o. |
Jan 21, 2015 | A Screening Program For Vision threatening Diseases (vtd) That Will Now Be Offered In Azur Retirement Residences Operated By The Cogir Management Corporation |
Dec 11, 2014 | Alexandria Minerals Corporation Will Use Diagnos' Cards Technology For Its Cadillac Break Properties |
Dec 3, 2014 | Diagnos And Puma Hit Again In The Turgeon South-Bern Zone In New Brunswick, Finding 2% Cu Over 6 Meters |
Nov 25, 2014 | Opens Mexican Subsidiary Diagnos Internacional, S.a. De C.v. |
Nov 19, 2014 | Resignation To The Board Of Directors |
Oct 16, 2014 | The Opening Of A Clinical Retinopathy Screening Office In Algeria |
Oct 2, 2014 | Healthcare's Commercialization Of Cara Passes $1m In Bookings |
Sep 25, 2014 | Amendment To Its Stock Option Plan |
Sep 16, 2014 | Contract With Dr. Kovil's Diabetes Care Centre In Mumbai |
Sep 9, 2014 | Contract With Dr. Vishal Gupta's Diabetes And Endocrine Clinic In Mumbai |
Sep 8, 2014 | Grant Of Stock Options |
Sep 3, 2014 | First Retinopathy Screening Unit In Turkey |
Aug 26, 2014 | First Retinopathy Screening Unit In Eastern Europe |
Aug 21, 2014 | First Screening Unit In Argentina |
Jul 24, 2014 | Changes To Its Board Of Directors |
Jul 22, 2014 | Yet Another Expansion Of Successful Program In The UAE |
Jul 16, 2014 | Signing Of Contract With Ministry Of Health Owned Medical Center In The United Arab Emirates |
Jul 11, 2014 | Persistence Capital Partners Files Early Warning Report |
Jul 10, 2014 | Property Asset or Share Purchase Agreement |
Jul 10, 2014 | Declaration of Distribution |
Jul 8, 2014 | Completes Merger With Warnex Inc. And Announces The Issuance Of Stock Warrants |
Jun 27, 2014 | Shareholders Of Warnex Approve The Amalgamation With Diagnos |
Jun 25, 2014 | Received TSX V Approval and Waives Due Diligence Condition to Amalgamation with Diagnos |
Jun 2, 2014 | Warnex And Diagnos Enter into a Pre Amalgamation Agreement |
May 6, 2014 | Final Closing Of Private Placement |
May 5, 2014 | Warnex To merge with Diagnos |
Apr 1, 2014 | Closing Of First Tranche Of Private Placement |
Mar 11, 2014 | An Additional Expansion Of Successful Program In The Uae |
Feb 25, 2014 | Private Placement |
Feb 12, 2014 | Three Year Contract With First U.s. Based Primary Care Network, Chaparral Medical Group In California |
Jan 13, 2014 | Healthcare (india) Pvt. Ltd. Announces The Signing Of A Letter Of Intent With Aditya Jyot A Leading Indian Ophthalmic Research And Treatment Eye Hospital |
Dec 18, 2013 | Puma Exploration Samples 6.5% Copper On Diagnos Cards Generated Targets On The Southern Part Of The Turgeon Project In New Brunswick |
Dec 17, 2013 | The Signing Of A Contract With A Major Pharma In India Following The Letter Of Intent Announcement In September 2013 |
Nov 26, 2013 | Contract Renewal And Expansion In The Uae |
Oct 10, 2013 | Impressive Results For The Automatic Detection Of Age related Macular Degeneration Using Cara Algorithms |
Sep 25, 2013 | Launches Manageo, A Turnkey, Web based Mining Claim Management Service |
Sep 18, 2013 | The Creation Of Indian Subsidiary And The Opening Of An Office In India |
Sep 11, 2013 | Completes $2.2 Million Exploration Mission Under Quebec's Plan Nord |
Sep 5, 2013 | Grant Of Stock Options |
Sep 4, 2013 | Signing Of A Letter Of Intent With A Major Global Pharma In India |
|
|
| You can return to the Top of this page
|
|